Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma.
about
Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysisGlycogen synthase kinase-3β is associated with the prognosis of hepatocellular carcinoma and may mediate the influence of type 2 diabetes mellitus on hepatocellular carcinoma.Diabetic patients with severe sepsis admitted to intensive care unit do not fare worse than non-diabetic patients: a nationwide population-based cohort study.Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after curative hepatectomy.Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer RiskThe Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in AsiaThe Relationship of Diabetes and Smoking Status to Hepatocellular Carcinoma MortalityIncreased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitusEmerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinomaBlood Neutrophil-to-Lymphocyte Ratio Predicts Tumor Recurrence in Patients with Hepatocellular Carcinoma within Milan Criteria after HepatectomyNational Policies Fostering Hospice Care Increased Hospice Utilization and Reduced the Invasiveness of End-of-Life Care for Cancer Patients.Diabetes mellitus and the neutrophil to lymphocyte ratio predict overall survival in non-viral hepatocellular carcinoma treated with transarterial chemoembolization.Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposureImpact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib.
P2860
Q26864963-602D50B3-B3E5-491D-A9AC-7EB9F14C8E1FQ34089689-0B5E48A5-D9CE-42B1-8446-E93065CB9199Q34510465-0E88E0A4-6136-46B8-96BE-91960E4F9417Q34600849-35216C58-A494-4010-B3E5-0D2A8F56FC77Q35649664-EE8EEDD8-29AA-4469-BA5A-CC382F914C81Q36064889-EE057B4C-90A8-4DF1-B1F6-86B07714A4E0Q36580952-95A28935-6C0B-4EBE-9AD0-E4A1BC3A58C7Q36783220-4375DDFB-756F-43FD-9F90-6E7208666E6CQ37031730-A6A9CA6B-E24F-4CF8-8E51-A7CECA36AB99Q37124765-67A24230-AF69-4864-875A-74DFC9FB71B6Q38837586-DDF9F6C8-B991-4357-8C13-7EE50E8A901DQ38933155-253BA653-13EB-4316-99AC-2D9CC1889FA6Q41931500-B0218999-48E9-4340-8F25-1DD94AC08886Q51833803-34EA3C47-F8A8-41F1-8703-1DE14082C7F7
P2860
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Diabetes mellitus is associate ...... for hepatocellular carcinoma.
@ast
Diabetes mellitus is associate ...... for hepatocellular carcinoma.
@en
type
label
Diabetes mellitus is associate ...... for hepatocellular carcinoma.
@ast
Diabetes mellitus is associate ...... for hepatocellular carcinoma.
@en
prefLabel
Diabetes mellitus is associate ...... for hepatocellular carcinoma.
@ast
Diabetes mellitus is associate ...... for hepatocellular carcinoma.
@en
P2093
P2860
P50
P1433
P1476
Diabetes mellitus is associate ...... for hepatocellular carcinoma.
@en
P2093
Wen-Yi Shau
Yi-Chun Yeh
Zhong-Zhe Lin
P2860
P304
P356
10.1634/THEONCOLOGIST.2012-0065
P577
2012-05-23T00:00:00Z